Patent · US Active

Antibodies to T cell immunoreceptor with IG and ITIM domains (TIGIT) and uses thereof

US10973853B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

I-MAB BIOPHARMA US LIMITED · US

Inventors

Feifei Cui · Shanghai, CN
Lei Fang · Katy, US
Bingshi Guo · Shanghai, CN
Zhengyi Wang · Shanghai, CN
Jingwu Zang · Shanghai, CN

Key dates

Filing date	Feb 11, 2019
Grant date	Apr 13, 2021
Priority date	—
Expiry date	Mar 31, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides antibodies and fragments thereof having specificity to a human T cell immunoreceptor with Ig and ITIM domains (TIGIT) protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and viral infections are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.